作为医药中间体,用于相关药物分子的合成。
医药中间体
合成路线 1(1. 合成:161157-50-2)
产率:94%
合成条件:With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 16 h;
实验步骤:根据WO 97/10212,向5,6-二氢吡啶-1(2H) - 羧酸叔丁酯(2.00g,10.9mmol)的DCM溶液中加入MCPBA(4.16g,18.6mmol)并搅拌混合物。 持续16个小时。 然后用饱和焦亚硫酸钠水溶液,饱和碳酸氢钠水溶液,1N NaOH和盐水洗涤。 将有机层干燥(硫酸钠),过滤,并真空浓缩,得到7-氧杂-3-氮杂 - 双环[4.1.0]庚烷-3-羧酸叔丁酯(2.04g,94%),为油状物: 1 H NMR(400MHz,CDCl 3)δ1-45(s,9H),1。 91(m,IH),2。 04(br,IH),3。 11(m,IH),3。 21(br,IH),3。 29(m,IH),3。 45(br,IH),3。 70(br,IH),3。 88(br,IH)。
参考文献:
- [1] Tetrahedron Letters, 2004, vol. 45, # 37, p. 6841 - 6845 [2] Organic Process Research and Development, 2014, vol. 18, # 2, p. 321 - 330 [3] Patent: WO2008/11130, 2008, A2. Location in patent: Page/Page column 136-137 [4] Patent: WO2013/138210, 2013, A1. Location in patent: Paragraph 0243 [5] European Journal of Medicinal Chemistry, 2018, vol. 150, p. 39 - 52 [6] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 16, p. 4523 - 4526 [7] Heterocycles, 1994, vol. 39, # 1, p. 163 - 170 [8] Patent: WO2006/104356, 2006, A1. Location in patent: Page/Page column 90 [9] Patent: WO2014/108168, 2014, A1. Location in patent: Page/Page column 71; 72 [10] Patent: WO2004/2490, 2004, A2. Location in patent: Page/Page column 46 [11] Patent: WO2014/197345, 2014, A2. Location in patent: Page/Page column 64; 65 [12] Tetrahedron, 2014, vol. 70, # 25, p. 3893 - 3900 [13] Patent: WO2004/82687, 2004, A1. Location in patent: Page/Page column 166 [14] Patent: EP3192791, 2017, A1. Location in patent: Paragraph 0656 [15] Journal of Medicinal Chemistry, 1994, vol. 37, # 16, p. 2574 - 2582 [16] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 21, p. 5853 - 5857 [17] Patent: US6051712, 2000, A [18] Patent: US2007/78165, 2007, A1. Location in patent: Page/Page column 5-6 [19] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 4, p. 1402 - 1406 [20] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 18, p. 5063 - 5065 [21] Patent: WO2009/53715, 2009, A1. Location in patent: Page/Page column 104 [22] Patent: US2005/197339, 2005, A1. Location in patent: Page/Page column 31 [23] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 13, p. 3903 - 3905 [24] Patent: WO2011/25851, 2011, A1. Location in patent: Page/Page column 86 [25] Beilstein Journal of Organic Chemistry, 2011, vol. 7, p. 1494 - 1498 [26] Patent: WO2012/31024, 2012, A1. Location in patent: Page/Page column 131 [27] Patent: US2014/179680, 2014, A1. Location in patent: Paragraph 0743 [28] Patent: WO2014/194519, 2014, A1. Location in patent: Page/Page column 58-59 [29] Patent: US2015/158864, 2015, A1. Location in patent: Paragraph 0470 [30] Patent: WO2015/95097, 2015, A2. Location in patent: Page/Page column 36; 54 [31] Patent: WO2016/128465, 2016, A1. Location in patent: Page/Page column 205 [32] Patent: US6355640, 2002, B1. Location in patent: Page column 33 [33] Patent: EP3287441, 2018, A1. Location in patent: Paragraph 0502
合成路线 2(2. 合成:161157-50-2)
产率:99%
合成条件:With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 0 - 20℃; for 3.25 h;
实验步骤:步骤A:将m-CPBA(7.53g,32.7mmol)的DCM(10mL)溶液加入到5,6-二氢吡啶-1(2H) - 羧酸叔丁酯(5.00g, 在0℃下,在DCM(20mL)中的27.3mmol)。 将反应在0℃下搅拌15分钟,然后在室温下搅拌3小时。 加入饱和亚硫酸钠溶液(20mL)和饱和碳酸氢钠溶液(30mL)。 分离有机层,用盐水洗涤,干燥(硫酸钠)并真空浓缩,得到7-氧杂-3-氮杂双环[4.1.0]庚烷-3-羧酸叔丁酯(5.36g,99%),为油状物。
参考文献:
- [1] Patent: WO2009/140320, 2009, A1. Location in patent: Page/Page column 77